Furthermore, DS side chains on other PGs such as biglycan, versican, epiphycan, endocan, and thrombomodulin may be affected by these mutations, which contribute to the wide range of the clinical manifestations of D4ST1-deficient EDS. This evidence concerns the gene CHST14 and Ehlers-Danlos syndrome.